Amylyx Pharmaceuticals, Inc. (AMLX) stock
AMLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$30.29+0.43 (+1.44%)
Close on Nov 13, 2026Market cap $3.38BP/E –Yield –
Amylyx Pharmaceuticals r&d expenses
Research and development expenses are spending on new products and technology.
Amylyx Pharmaceuticals's R&D Expenses for the twelve months ending Sep 30, 2026 was $100.94M, up 9.6% year over year. For fiscal 2025 it was $90.40M, down 13.1% from the year before. The highest annual figure on record is $128.19M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $90.40M | -13.1% |
| FY2024 | Dec 31, 2024 | $104.08M | -18.8% |
| FY2023 | Dec 31, 2023 | $128.19M | +37.2% |
| FY2022 | Dec 31, 2022 | $93.45M | +112.2% |
| FY2021 | Dec 31, 2021 | $44.04M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $28.35M | +42.8% |
| Q2 FY2026 | Jun 30, 2026 | $23.77M | -12.7% |
| Q1 FY2026 | Mar 31, 2026 | $27.61M | +24.8% |
| Q4 FY2025 | Dec 31, 2025 | $21.21M | -7.3% |
| Q3 FY2025 | Sep 30, 2025 | $19.86M | -6.5% |
| Q2 FY2025 | Jun 30, 2025 | $27.22M | +16.6% |
| Q1 FY2025 | Mar 31, 2025 | $22.12M | -39.6% |
| Q4 FY2024 | Dec 31, 2024 | $22.89M | -49.0% |
| Q3 FY2024 | Sep 30, 2024 | $21.24M | -29.3% |
| Q2 FY2024 | Jun 30, 2024 | $23.35M | -19.6% |
| Q1 FY2024 | Mar 31, 2024 | $36.61M | +51.3% |
| Q4 FY2023 | Dec 31, 2023 | $44.91M | +96.9% |
| Q3 FY2023 | Sep 30, 2023 | $30.04M | +20.6% |
| Q2 FY2023 | Jun 30, 2023 | $29.04M | +19.7% |
| Q1 FY2023 | Mar 31, 2023 | $24.19M | +12.7% |
| Q4 FY2022 | Dec 31, 2022 | $22.81M | +70.3% |
| Q3 FY2022 | Sep 30, 2022 | $24.91M | +93.8% |
| Q2 FY2022 | Jun 30, 2022 | $24.26M | +122.0% |
| Q1 FY2022 | Mar 31, 2022 | $21.46M | +212.7% |
| Q4 FY2021 | Dec 31, 2021 | $13.39M | – |
| Q3 FY2021 | Sep 30, 2021 | $12.85M | – |
| Q2 FY2021 | Jun 30, 2021 | $10.93M | – |
| Q1 FY2021 | Mar 31, 2021 | $6.86M | – |
See a number that looks wrong?